Saratoga Investment Earnings Calls
| Release date | Jul 07, 2026 |
| EPS estimate | $0.540 |
| EPS actual | $0.470 |
| EPS Surprise | -12.96% |
| Revenue estimate | 31.379M |
| Revenue actual | 30.777M |
| Revenue Surprise | -1.92% |
| Release date | May 05, 2026 |
| EPS estimate | $0.530 |
| EPS actual | $0.530 |
| Revenue estimate | 30.853M |
| Revenue actual | 31.123M |
| Revenue Surprise | 0.87% |
| Release date | Jan 07, 2026 |
| EPS estimate | $0.590 |
| EPS actual | $0.610 |
| EPS Surprise | 3.39% |
| Revenue estimate | 30.94M |
| Revenue actual | 31.646M |
| Revenue Surprise | 2.28% |
| Release date | Oct 07, 2025 |
| EPS estimate | $0.670 |
| EPS actual | $0.580 |
| EPS Surprise | -13.43% |
| Revenue estimate | 32.51M |
| Revenue actual | 32.626M |
| Revenue Surprise | 0.355% |
Last 4 Quarters for Saratoga Investment
Below you can see how SAR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 07, 2025 |
| Price on release | $23.35 |
| EPS estimate | $0.670 |
| EPS actual | $0.580 |
| EPS surprise | -13.43% |
| Date | Price |
|---|---|
| Oct 01, 2025 | $24.10 |
| Oct 02, 2025 | $24.49 |
| Oct 03, 2025 | $24.40 |
| Oct 06, 2025 | $24.41 |
| Oct 07, 2025 | $23.35 |
| Oct 08, 2025 | $22.25 |
| Oct 09, 2025 | $22.05 |
| Oct 10, 2025 | $21.59 |
| Oct 13, 2025 | $21.87 |
| 4 days before | -3.11% |
| 4 days after | -6.34% |
| On release day | -4.71% |
| Change in period | -9.25% |
| Release date | Jan 07, 2026 |
| Price on release | $22.59 |
| EPS estimate | $0.590 |
| EPS actual | $0.610 |
| EPS surprise | 3.39% |
| Date | Price |
|---|---|
| Dec 31, 2025 | $23.07 |
| Jan 02, 2026 | $23.17 |
| Jan 05, 2026 | $23.55 |
| Jan 06, 2026 | $23.19 |
| Jan 07, 2026 | $22.59 |
| Jan 08, 2026 | $22.94 |
| Jan 09, 2026 | $23.22 |
| Jan 12, 2026 | $23.12 |
| Jan 13, 2026 | $23.01 |
| 4 days before | -2.08% |
| 4 days after | 1.86% |
| On release day | 1.55% |
| Change in period | -0.260% |
| Release date | May 05, 2026 |
| Price on release | $23.22 |
| EPS estimate | $0.530 |
| EPS actual | $0.530 |
| Date | Price |
|---|---|
| Apr 29, 2026 | $22.67 |
| Apr 30, 2026 | $23.30 |
| May 01, 2026 | $23.53 |
| May 04, 2026 | $23.89 |
| May 05, 2026 | $23.22 |
| May 06, 2026 | $22.50 |
| May 07, 2026 | $22.34 |
| May 08, 2026 | $22.15 |
| May 11, 2026 | $21.83 |
| 4 days before | 2.43% |
| 4 days after | -5.99% |
| On release day | -3.10% |
| Change in period | -3.71% |
| Release date | Jul 07, 2026 |
| Price on release | $20.93 |
| EPS estimate | $0.540 |
| EPS actual | $0.470 |
| EPS surprise | -12.96% |
| Date | Price |
|---|---|
| Jun 30, 2026 | $22.31 |
| Jul 01, 2026 | $22.54 |
| Jul 02, 2026 | $22.36 |
| Jul 06, 2026 | $21.42 |
| Jul 07, 2026 | $20.93 |
| Jul 08, 2026 | $17.98 |
| Jul 09, 2026 | $17.45 |
| Jul 10, 2026 | $18.17 |
| Jul 13, 2026 | $19.05 |
| 4 days before | -6.19% |
| 4 days after | -8.98% |
| On release day | -14.09% |
| Change in period | -14.61% |
Saratoga Investment Earnings Call Transcript Summary of Q2 2026
Key points for investors: Saratoga posted sequential and year-over-year NAV growth (NAV $410.5M; NAV per share $25.61). Adjusted NII declined materially versus last year and slightly versus last quarter (adjusted NII per share $0.58) driven by lower short-term rates, elevated repayments, and share dilution from ATM/DRIP issuance. Management declared a quarterly aggregate dividend of $0.75 ($0.25/month), representing a ~12.3% annualized yield on the cited stock price; the Board will review dividends quarterly. Credit quality is strong: portfolio fair value ~$995M, 84% first-lien, only one investment remains on nonaccrual (~0.2% of portfolio), and core non‑CLO portfolio is marked above cost. Liquidity/“dry powder” is a key strength — $201M cash and total available liquidity of ~$407M (including SBA debentures and undrawn credit), enabling accretive deployment without external financing. Originations were $52.2M in the quarter (mix of follow-ons and BB/BBB CLO debt), and management is increasing exposure to select CLO BB/BBB tranches as a diversifier and yield source. Management emphasizes disciplined underwriting and business development to grow deal flow but notes a highly competitive lower-middle-market with compressed spreads and elevated lender competition. Outlook/risk points: lower short‑term rates have pressured yields and NII; repayments create lumpiness in earnings; competition and looser covenant terms from some entrants are a market risk, but management states they will remain selective and focused on underwriting and NAV preservation. Longer-term metrics remain favorable: latest 12‑month ROE ~9.1% (above industry) and multi-year realized return track record cited.
Sign In
Buy SAR